Alex Raeber

Alex is a C-level and board senior executive who brings more than 30 years’ leadership experience of increasing responsibility in R&D and management, including 20 years in agribusiness, sustainable food production and animal health industries. He is a passionate innovator with a successful track record of building profitable businesses through disruptive product innovations from start-up companies to multinationals. Alex joined the Board of Directors of SAFOSO in May 2021.

Alex holds a Master’s degree and a PhD in Natural Sciences from the Swiss Federal Institute of Technology (ETH) in Zürich and pursued a successful academic career at the University of California in San Francisco and the University of Zurich authoring more than 60 papers in peer-reviewed journals and having contributed to more than 10 book chapters.

Before joining SAFOSO, Alex was the Chief Scientific Officer and served on the Board of Directors at Benchmark Holdings plc, the UK listed global aquaculture health, nutrition and genetics company driving sustainability in food production. He joined Benchmark in 2018 from Thermo Fisher Scientific where he held positions as the Director Global R&D for Agribusiness and Managing Director for the Thermo Fisher Scientific Zurich site. Prior to this, he was the Chief Scientific Officer of Swiss based Prionics AG which pioneered diagnostic testing for BSE and he also was a member of the Management Board which successfully sold the company to Thermo Fisher Scientific in 2014. Before that, Alex was the CSO for Cytos Proteome Therapeutics and served for more than 10 years on the Board of Directors of BioSupport AG, a technology provider to companies in the Bio-Technopark Zurich.